03 · What You Need to Know
Why Societal Value Cannot Simply Be Traded Against Individual Harm
Benefits to Society Are Ethically Relevant
Research would make little ethical sense if benefits to people beyond the individual participant could never matter. Much research exists precisely to generate knowledge that improves future care, prevention, policy, practice, or scientific understanding.
The Belmont Report explicitly recognizes benefits to society through knowledge gained from research. It states that interests other than those of the immediate participant may on some occasions be sufficient by themselves to justify research risks, provided participants' rights have been protected.
CIOMS similarly requires social and scientific value before any research risks are imposed on participants.
So societal value belongs in the ethical analysis. The difficult issue is how much work it can legitimately do.
The Participant's Interests Normally Carry Special Weight
Belmont does not treat benefits to participants and benefits to society as interchangeable entries in a ledger. In balancing different risks and benefits, it states that those affecting the immediate participant normally carry special weight.
This creates an important asymmetry. A modest individual risk may sometimes be justified primarily by valuable knowledge for others. But one cannot assume that increasing the number of future beneficiaries indefinitely makes any magnitude of individual harm acceptable.
The participant remains a person whose welfare and rights require protection, not merely the location where society temporarily stores research risk.
Risk-Benefit Assessment Is Not Utilitarian Arithmetic
Suppose a study creates a 20% probability of serious harm for ten participants but could eventually improve care for one million people. Those numbers alone do not answer whether the study is ethical.
The assessment must ask whether the study is scientifically valid, whether human participation is necessary, whether a safer design exists, whether participants themselves might benefit, what type of harm is possible, whether participants can provide valid consent, whether particular risk limits apply, and whether the people bearing the risk have been selected fairly.
This is why a proper risk-benefit assessment cannot ordinarily be reduced to total expected benefit minus total expected harm.
Risk Must Be Minimized Before Societal Value Is Used to Justify What Remains
Researchers should not defend an avoidable risk by emphasizing how valuable the resulting knowledge could be.
Belmont states that risks should be reduced to those necessary to achieve the research objective and that alternative procedures should be considered. CIOMS requires risks to be minimized before they are balanced against potential individual benefit and social and scientific value.
Thus the ethically relevant risk is residual risk after appropriate minimization.
Ask whether humans are needed
Could the question be answered adequately without exposing human participants to this risk?
Remove unnecessary exposure
Does every risky intervention, procedure, measurement, or data collection element contribute sufficiently to the objective?
Use safer adequate alternatives
Can probability or magnitude of harm be reduced without making the study scientifically uninformative?
Then assess societal justification
Only the necessary residual risk should be evaluated against potential individual benefits and the scientific and social value of the knowledge.
Substantial Risk Requires More Than a More Impressive Research Question
Belmont states that when research involves significant risk of serious impairment, review committees should be extraordinarily insistent on justification. It notes that such justification will usually look to the likelihood of benefit to the participant or, in rare cases, to the manifest voluntariness of participation. It also states unequivocally that brutal or inhumane treatment is never morally justified.
These statements matter because they reject a simple proposition that enough social value can always outweigh enough individual risk.
The ethical burden of justification increases as the potential harm becomes more serious. At some point, applicable principles or regulations may constrain the exposure regardless of the projected number of future beneficiaries.
Direct Benefit Changes What Can Justify Risk
Consider two risky procedures. One is an experimental intervention that may improve the participant's serious illness. The other is an invasive research-only procedure that cannot help the participant but produces useful scientific information.
CIOMS evaluates these differently. Procedures offering potential individual benefit can be assessed partly in relation to that prospect. Procedures without potential individual benefit depend more heavily on scientific and social value and are subject to applicable limits on permissible risk.
This is why identifying whether a procedure can benefit the participant directly is not merely a consent-form detail. It affects the ethical structure of the risk justification.
Do Not Let a Beneficial Intervention Justify an Unrelated Research-Only Risk
A single protocol can contain both types of procedures. An experimental treatment may offer potential direct benefit while biopsies, blood draws, imaging, or questionnaires are included solely to generate research information.
The possible benefit of the treatment should not automatically be used to justify every research-only procedure. CIOMS recommends evaluating individual interventions and procedures before considering the study as a whole.
This prevents a scientifically exciting study from carrying ethically weak procedures as unnoticed passengers.
Consent Matters Greatly, but It Is Not a Waiver of Ethical Limits
A competent adult may freely choose to accept substantial risk for the benefit of others. People make altruistic choices outside research as well, from living organ donation to dangerous forms of public service.
The World Medical Association's 2024 revision materials recognize that research participants may make freely chosen decisions to take risks for the good of others with minimal expectation of personal benefit.
That voluntariness can matter greatly, particularly when risk is substantial. But informed consent answers whether a person autonomously accepts an ethically permissible offer. It does not establish by itself that researchers were entitled to make the offer.
Watch Out
“They knew the risk and agreed” is not a complete ethical justification for substantial research risk. Consent is indispensable in many studies, but risk minimization, scientific necessity, independent review, fair selection, and applicable risk limits remain.
Vulnerability Can Narrow What Societal Benefit Can Justify
The same societal benefit does not necessarily justify the same risk in every population.
Belmont calls for special scrutiny when vulnerable populations are involved and emphasizes the appropriateness of involving them in light of the nature and degree of risk, their circumstances, and anticipated benefits. It also warns against placing research burdens disproportionately on groups selected because of compromised position or easy availability.
The Declaration of Helsinki requires specific protection for individuals, groups, and communities in situations of vulnerability and attention to the distribution of benefits, risks, and burdens.
Societal importance therefore cannot be separated from the justice question: who is being asked to bear the danger required to produce that societal good?
Some Populations Have Explicit Regulatory Risk Limits
General ethical principles are not the only constraints. Specific regulations may restrict the risk permissible in research without direct benefit for particular participant groups.
This is especially important in pediatric research, where regulatory frameworks may distinguish research offering a prospect of direct benefit from research that does not and impose additional conditions on the latter. The underlying logic is straightforward: people with limited ability to authorize substantial altruistic risk for themselves may require stronger protection.
Researchers should therefore consult the actual rules governing their participant population rather than infer permissible risk from general statements about social value.
The Value Must Be Expected From This Study, Not From the Topic in General
A study of cancer, climate-related health effects, suicide prevention, or another serious problem may sound socially valuable by definition. Yet the ethical justification concerns the knowledge that this protocol can reasonably be expected to produce.
If the study is underpowered, methodologically incapable of answering its question, needlessly duplicative, or unlikely to yield interpretable results, its topic cannot supply the missing value.
This is why the importance of research knowledge and the amount of acceptable risk cannot be separated from scientific validity.
Distribution Matters, Not Just Total Benefit
A study can produce substantial aggregate benefit while distributing burdens unfairly.
Belmont's principle of justice asks who receives the benefits of research and who bears its burdens. It specifically warns against patterns in which disadvantaged populations serve disproportionately as research participants while more advantaged groups receive the resulting benefits.
The Declaration of Helsinki likewise requires consideration of how benefits, risks, and burdens are distributed.
An ethics assessment should therefore ask not merely “How many people might benefit?” but also “Who bears the risk, why them, and are they reasonably positioned to share in the value the research is intended to create?”
Some Ethical Limits Are Not Meant to Be Outweighed
Risk-benefit language can create the impression that every ethical concern is negotiable if enough benefit appears on the other side. Belmont explicitly rejects that interpretation by stating that brutal or inhumane treatment is never morally justified.
Other limits may arise from specific laws, regulations, ethical guidelines, participant characteristics, or the nature of the procedure.
So the question is not simply how large the societal benefit is. It is first whether the proposed exposure falls within the range of risks that may ethically be considered for justification at all.
